Literature DB >> 17141335

Enhancing effects of chronic lithium on memory in the rat.

Eleftheria Tsaltas1, Dimitrios Kontis, Vasileios Boulougouris, Vasiliki-Maria Papakosta, Haralambos Giannou, Cornelia Poulopoulou, Constantine Soldatos.   

Abstract

BACKGROUND: In spite of recent enrichment of neurochemical and behavioural data establishing a neuroprotective role for lithium, its primary effects on cognitive functioning remain ambiguous. This study examines chronic lithium effects on spatial working memory and long-term retention.
METHODS: In three discrete experiments, rats subjected to 30 daily intraperitoneal injections (2mmol/kg) of lithium (lithium groups: serum lithium=0.5+/-0.4mEq/l, 12h post-injection) or saline (controls) were trained in 0-s delay T-maze alternation and then tested in 30-, 45- and 60-s delay alternation (Experiments 1, 2, 3, respectively). Animals from Experiment 1 were further tested in one-trial step-through passive avoidance under mild shock parameters (0.5mA, 1s). Retention was assessed 6h later. Daily lithium or saline injections continued throughout behavioural testing.
RESULTS: Lithium animals were indistinguishable from controls during 0-delay alternation baseline (Experiments 1-3, accuracy>88%) but showed significantly higher accuracy than controls at 30- and 45-s delays (93% versus 85% and 92% versus 82%, Experiments 1 and 2, respectively). At 60-s delay (Experiment 3) this beneficial effect of lithium was no longer apparent (lithium and control accuracy=78%). In Experiment 4, the shock used did not support 6-h passive avoidance retention in controls, whereas lithium animals showed significant step-through latency increases.
CONCLUSIONS: Chronic lithium enhanced spatial working memory and promoted long-term retention of a weak aversive contingency. The results suggest that lithium may have potential as a cognitive enhancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141335     DOI: 10.1016/j.bbr.2006.11.003

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  13 in total

1.  Lithium prevents REM sleep deprivation-induced impairments on memory consolidation.

Authors:  Simone M Ota; Karin Di Monteiro Moreira; Deborah Suchecki; Maria Gabriela M Oliveira; Paula A Tiba
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

2.  Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.

Authors:  Zhong-Hua Liu; De-Maw Chuang; Carolyn Beebe Smith
Journal:  Int J Neuropsychopharmacol       Date:  2010-05-25       Impact factor: 5.176

Review 3.  Lithium: a promising treatment for fragile X syndrome.

Authors:  Zhonghua Liu; Carolyn Beebe Smith
Journal:  ACS Chem Neurosci       Date:  2014-05-15       Impact factor: 4.418

Review 4.  Lithium and cognitive enhancement: leave it or take it?

Authors:  Eleftheria Tsaltas; Dimitris Kontis; Vasileios Boulougouris; George N Papadimitriou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-10       Impact factor: 4.530

5.  Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.

Authors:  Dimitris Kontis; Vasileios Boulougouris; Vasiliki Maria Papakosta; Stamatina Kalogerakou; Socrates Papadopoulos; Cornelia Poulopoulou; George N Papadimitriou; Eleftheria Tsaltas
Journal:  Psychopharmacology (Berl)       Date:  2008-07-14       Impact factor: 4.530

Review 6.  Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.

Authors:  Margaret K King; Marta Pardo; Yuyan Cheng; Kimberlee Downey; Richard S Jope; Eléonore Beurel
Journal:  Pharmacol Ther       Date:  2013-07-31       Impact factor: 12.310

Review 7.  The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.

Authors:  Kelley C O'Donnell; Todd D Gould
Journal:  Neurosci Biobehav Rev       Date:  2007-04-13       Impact factor: 8.989

8.  Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.

Authors:  Christopher J Yuskaitis; Marjelo A Mines; Margaret K King; J David Sweatt; Courtney A Miller; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

9.  Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer's disease.

Authors:  Fábio B Mury; Weber C da Silva; Nádia R Barbosa; Camila T Mendes; Juliana S Bonini; Jorge Eduardo Souza Sarkis; Martin Cammarota; Ivan Izquierdo; Wagner F Gattaz; Emmanuel Dias-Neto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-12-11       Impact factor: 5.270

10.  GSK-3 in Neurodegenerative Diseases.

Authors:  Peng Lei; Scott Ayton; Ashley I Bush; Paul A Adlard
Journal:  Int J Alzheimers Dis       Date:  2011-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.